KTC
ENZN

Kistler-Tiffany Companies’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Kistler-Tiffany Companies’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-825
Closed – – 758
2016
Q2 		$0 Hold
825
– – ﹤0.01% 776
2016
Q1 		$0 Hold
825
– – ﹤0.01% 614
2015
Q4 		$1K Hold
825
– – ﹤0.01% 589
2015
Q3 		$1K Sell
825
-1,460
-64% -$1.8K ﹤0.01% 594
2015
Q2 		$3K Buy
2,285
+1,460
+177% +$1.86K ﹤0.01% 550
2015
Q1 		$1K Hold
825
– – ﹤0.01% 574
2014
Q4 		$1K Hold
825
– – ﹤0.01% 583
2014
Q3 		$1K Hold
825
– – ﹤0.01% 593
2014
Q2 		$1K Hold
825
– – ﹤0.01% 572
2014
Q1 		$1K Hold
825
– – ﹤0.01% 555
2013
Q4 		$1K Hold
825
– – ﹤0.01% 559
2013
Q3 		$1K Hold
825
– – ﹤0.01% 553
2013
Q2 		$2K Buy
+825
New +$2.42K ﹤0.01% 543

Other funds holding ENZN

PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Kistler-Tiffany Companies's ENZN Position: Q3 2016 in Review

Kistler-Tiffany Companies sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2016, closing a stake of 825 shares.

Kistler-Tiffany Companies first reported a position in ENZN in Q2 2013 and held it in 13 quarters. The position peaked at $3K in Q2 2015. 4 funds tracked by Wall St. Rank hold ENZN as of Q3 2016.

  • Kistler-Tiffany Companies reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2016 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 825 ENZON PHARMACEUTICALS INC shares in Q3 2016.
  • Kistler-Tiffany Companies first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 13 quarters.
  • Kistler-Tiffany Companies's ENZON PHARMACEUTICALS INC position peaked at $3K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2016.

Based on Kistler-Tiffany Companies's 13F filing for Q3 2016, filed 8 Nov 2016.